Twitxy
Saved
@Rod_Peralvarez's profile picture
View on X

Manuel Luis Rodríguez Perálvarez

@Rod_Peralvarez

Liver doctor juggling with family, medicine, teaching and research… FUN
Córdoba linkedin.com/in/manuel-rodr… Joined May 2022
387 Following 417 Followers 1.4K Posts

Latest posts 5

Manuel Luis Rodríguez Perálvarez @Rod_Peralvarez
Around 6% of rejections after liver transplant are steroid-resistant according to this syst rev, which give us aprox prevalence 0.6% (likely overestimated). Anyhow, if you face one case, you may never forget.
ILTS Liver Transplant Immunology SIG @IltsImmunology Aug 9
Steroid-resistant rejection is extremely uncommon after liver transplant but challenging to manage whenever happens. All you need to know in this systematic review and metaanalysis.

pubmed.ncbi.nlm.nih.gov/42571446/
View quoted post on X
Manuel Luis Rodríguez Perálvarez @Rod_Peralvarez
@rangelico85 took one for the team!!! Great presentation at @_ILTS_ in Geneva. More than 30 hospitals from 15 countries involved for the largest study on immunosuppression withdrawal after liver transplantation ever performed. 💪
ILTS Liver Transplant Immunology SIG @IltsImmunology May 8
@rangelico85 present on behalf of @IltsImmunology in Geneva the largest international study of immunosuppression withdrawal after liver transplant.
1- Feasible in selected pts
2- Associated with metabolic benefits in adults
3- Negligible risk of graft loss
4- Excellent survival
View quoted post on X
Manuel Luis Rodríguez Perálvarez @Rod_Peralvarez
La terapia con macrofagos modificados genéticamente abre una nueva oportunidad de tratamiento para nuestros pacientes con enfermedades hepáticas. Todo lo que necesitas saber en el link.

emeraldv3-mfehejtn.manus.space

@AEEHLiver @sapdes @IMIBIC
emeraldv3-mfehejtn.manus.space EMERALD Clinical Study | Córdoba Bilingual EMERALD Clinical Study website for Dr. Manuel Rodríguez, with Spanish-first editorial content and an embedded Vimeo interview.